• LAST PRICE
    20.8100
  • TODAY'S CHANGE (%)
    Trending Up0.6000 (2.9688%)
  • Bid / Lots
    20.3900/ 12
  • Ask / Lots
    21.9000/ 1
  • Open / Previous Close
    20.4700 / 20.2100
  • Day Range
    Low 20.0900
    High 21.2750
  • 52 Week Range
    Low 19.5200
    High 77.1300
  • Volume
    624,501
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 20.21
TimeVolumePRTA
09:32 ET244420.29
09:36 ET224520.63
09:38 ET20020.52
09:39 ET20020.565
09:41 ET20020.69
09:43 ET209221.035
09:45 ET40020.94
09:48 ET20020.94
09:50 ET44520.955
09:52 ET20021.05
09:54 ET90021.08
09:56 ET89320.98
09:57 ET70021.07
10:03 ET312120.9
10:06 ET90020.935
10:10 ET10020.79
10:14 ET10020.67
10:15 ET10020.63
10:17 ET31020.68
10:19 ET60020.765
10:21 ET40020.83
10:26 ET60020.87
10:28 ET170520.78
10:30 ET197520.94
10:32 ET120720.96
10:33 ET84021
10:35 ET10020.99
10:37 ET20020.985
10:39 ET40921.07
10:42 ET60021.07
10:44 ET30021.115
10:46 ET50020.99
10:48 ET110020.945
10:50 ET159020.9
10:53 ET20020.92
10:55 ET10020.935
11:00 ET43020.895
11:02 ET71520.895
11:04 ET10020.845
11:06 ET23820.7609
11:09 ET40020.79
11:11 ET94420.845
11:13 ET848020.85
11:15 ET200020.825
11:18 ET89620.84
11:20 ET10020.805
11:22 ET40020.805
11:24 ET77520.83
11:26 ET17920.835
11:29 ET20020.835
11:31 ET20020.84
11:33 ET60020.78
11:36 ET20320.795
11:38 ET10020.8
11:40 ET20020.72
11:42 ET30020.77
11:49 ET20020.82
11:54 ET150020.9
11:56 ET460321
12:03 ET10020.9977
12:07 ET81220.912
12:12 ET10020.92
12:14 ET416520.98
12:16 ET50021.015
12:18 ET98021.02
12:20 ET340020.99
12:21 ET2293021.14
12:23 ET244021.17
12:25 ET20021.15
12:27 ET110421.15
12:30 ET10021.15
12:34 ET232021.275
12:36 ET90021.24
12:39 ET10021.21
12:41 ET30021.18
12:43 ET80021.1
12:45 ET243721.09
12:48 ET546821.145
12:50 ET681121.17
12:52 ET195721.15
12:54 ET210021.15
12:56 ET10021.16
12:57 ET60021.18
12:59 ET95021.13
01:01 ET202221.13
01:03 ET149821.16
01:06 ET152520.96
01:08 ET227620.77
01:10 ET30020.785
01:14 ET112020.84
01:15 ET100020.76
01:17 ET82120.69
01:21 ET10020.69
01:24 ET20020.71
01:26 ET10020.74
01:28 ET10020.75
01:32 ET46120.7545
01:33 ET10020.75
01:37 ET30020.67
01:39 ET30020.7
01:42 ET30020.665
01:44 ET55520.7
01:46 ET60020.75
01:48 ET20520.75
01:50 ET20020.74
01:51 ET30020.745
01:53 ET60020.68
01:55 ET10020.67
01:57 ET20020.66
02:04 ET20020.565
02:06 ET66220.66
02:08 ET10020.63
02:09 ET90020.61
02:11 ET64820.585
02:20 ET108420.67
02:22 ET401320.7933
02:24 ET1551020.8
02:26 ET19420.805
02:27 ET90020.855
02:29 ET33620.86
02:31 ET40020.82
02:38 ET20020.87
02:40 ET589520.77
02:42 ET20020.75
02:44 ET76420.78
02:49 ET103620.7
02:54 ET20020.67
02:56 ET153620.67
02:58 ET20020.7
03:02 ET20020.69
03:03 ET10020.66
03:05 ET168420.66
03:07 ET90020.655
03:09 ET213320.65
03:12 ET91420.61
03:14 ET40320.62
03:20 ET217620.595
03:21 ET50020.6
03:23 ET60020.61
03:25 ET50020.58
03:27 ET40020.55
03:30 ET10020.55
03:32 ET217720.55
03:34 ET211620.65
03:38 ET40020.67
03:39 ET70020.66
03:41 ET93320.66
03:43 ET230020.67
03:45 ET110020.7
03:48 ET60020.7
03:50 ET504620.74
03:52 ET70020.76
03:54 ET303220.73
03:56 ET390320.78
03:57 ET608320.78
03:59 ET592920.81
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPRTA
Prothena Corporation PLC
1.1B
-6.4x
---
United StatesNRIX
Nurix Therapeutics Inc
934.0M
-5.9x
---
United StatesGYRE
Gyre Therapeutics Inc
971.4M
-6.0x
---
United StatesIMTX
Immatics NV
1.1B
-10.4x
---
United StatesVIR
Vir Biotechnology Inc
1.4B
-2.6x
---
United StatesCVAC
CureVac NV
872.5M
-2.9x
---
As of 2024-06-02

Company Information

Prothena Corporation plc is an Ireland-based late-stage clinical biotechnology company. The Company is engaged in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid diseases. The Company is advancing a pipeline of therapeutic candidates for a range of indications and targets to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins. The Company’s pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases, including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and a range of other neurodegenerative diseases. Its clinical programs include birtamimab for the potential treatment of AL amyloidosis, prasinezumab for the potential treatment of Parkinson’s disease, NNC6019/PRX004 for the potential treatment of ATTR amyloidosis, and PRX005 and PRX012 for the potential treatment of Alzheimer’s disease.

Contact Information

Headquarters
77 Sir John Rogersons Quay Block C, Grand Canal DocklandsDUBLIN, Ireland D02 T804
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Lars Ekman
President, Chief Executive Officer, Director
Gene Kinney
Chief Financial Officer, Chief Strategy Officer
Tran Nguyen
Chief Operating Officer
Brandon Smith
Chief Accounting Officer
Karin Walker

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.1B
Revenue (TTM)
$89.3M
Shares Outstanding
53.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.24
EPS
$-3.25
Book Value
$10.46
P/E Ratio
-6.4x
Price/Sales (TTM)
12.5
Price/Cash Flow (TTM)
---
Operating Margin
-242.28%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.